Strategies for Improving the Postmortem Neuropathological Diagnosis of Alzheimer’s Disease
Authors:
- C.M ClarkCCC.M Clark
- M.L SchmidtMSM.L Schmidt
- S.E ArnoldSAS.E Arnold
- V.M.-Y LeeVLV.M.-Y Lee
Open Access
- 1 July 1997
- journal article
- review article
- Published by Elsevier in Neurobiology of Aging
- Vol. 18 (4) , S75-S79
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseNature, 1995
- Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotypeAnnals of Neurology, 1995
- Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaquesNeuron, 1995
- Phosphorylation of Neuronal Cytoskeletal Proteins in Alzheimer's Disease and Lewy Body DementiasaAnnals of the New York Academy of Sciences, 1994
- Plaque-Associated Neuronal Proteins: A Recurrent Motif in Neuritic Amyloid Deposits throughout Diverse Cortical Areas of the Alzheimer's Disease BrainExperimental Neurology, 1994
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Alzheimer's disease and soluble AβNeurobiology of Aging, 1994
- Normal and Abnormal Biology of the beta-Amyloid Precursor ProteinAnnual Review of Neuroscience, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991